Caitlin was introduced to Aubrey and the longevity field in 2017, when she joined SENS Research Foundation’s MitoSENS project to develop engineered mitochondrial genes for therapeutic allotopic expression. In 2021 Caitlin began working with research leads at SRF on the strategic development of nascent projects, efforts which laid the foundation for her broader role at LEVF – evaluating areas of progress and stagnation across the entire longevity field, identifying neglected therapeutic targets, formulating novel interventions, and facilitating their development.
